With reference to the subject cited above, we hereby furnish the Annual Report for the Financial Year 2024-25 as per the Regulation 34(1) of the Securities and Exchange Board of India (Listing ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Phyto Chem (India) Ltd has submitted its 36th Annual Report for FY 2024-25 to BSE under Regulation 34 of SEBI LODR Regulations. Key financials show gross revenue of Rs. 1,655.11 lakhs (down from Rs. 1,712.96 lakhs in FY23-24), with operating loss narrowing to Rs. 104.83 lakhs from Rs. 333.93 lakhs in the previous year. The 36th AGM is scheduled for September 29, 2025. Agenda items include re-appointment of Managing Director Y. Nayudamma for 3 years at Rs. 2.5 lakh/month salary, re-appointment of two independent directors, and appointment of three new directors — notably Mr. Sreemannarayana Yarlagadda (MD's son, age 27) as Executive Director at Rs. 75,000/month. The report also cites several board exits and new appointments during the year.
Routine annual compliance filing with no material surprise on financials, but operating losses persist (though improved). Shareholders should note the related-party appointment of the MD's son to the executive board and review the director remuneration resolutions at the upcoming AGM.